The PMHNP is considering prescribing an antipsychotic agent for a 79-year-old man with moderate-stage Alzheimer’s dementia who is beginning to exhibit aggressive behavior towards his family. Prior to starting treatment, the PMHNP counsels the family that the medication is associated with:
QID: 3661797Mark For Review
Increased risk of wandering.
Accelerated cognitive decline.
Increased mortality rate.
Diminished vocal communication.